BD Celebrates 65 Years of Manufacturing Excellence and Innovation in Healthcare Solutions
- Becton, Dickinson and Company celebrates 65 years of manufacturing excellence at its Broken Bow facility on October 16, 2025.
- The Broken Bow facility, the world's largest manufacturer of BD Vacutainer® tubes, employs nearly 600 associates.
- BD has invested over $50 million since 2020 to modernize its Broken Bow facility and enhance healthcare delivery.
BD Celebrates Milestone in Manufacturing Excellence
Becton, Dickinson and Company (BD) marks a significant milestone at its Broken Bow, Nebraska facility, celebrating 65 years of manufacturing excellence on October 16, 2025. Established on October 18, 1960, this facility has evolved from a modest 13,753-square-foot building with just 20 employees to a sprawling 310,000-square-foot site that employs nearly 600 associates today. Recognized as the world's largest manufacturer of BD Vacutainer® tubes, the Broken Bow facility produces billions of these critical products annually, facilitating specimen collection in healthcare settings globally. Bridget Bagnato, the worldwide president of BD's Specimen Management business, commends the dedicated team for their pivotal role in enhancing patient care across the globe.
The company’s commitment to innovation and modernization is evident in its substantial investments in the Broken Bow facility, exceeding $50 million since 2020. Recent upgrades include advancements in its chemistry lab, which are vital for maintaining BD's competitive edge in the medical technology sector. BD operates four manufacturing sites in Nebraska, employing approximately 2,700 individuals and reinforcing its status as the largest manufacturer in the state. In line with its growth strategy, BD has announced an additional investment of over $35 million to bolster production at its Columbus facility, which will create 50 new jobs focused on prefilled flush syringes. This initiative not only enhances the resilience of the U.S. healthcare system but also underscores BD’s dedication to supporting local communities.
As BD continues to expand its manufacturing capabilities, the company’s focus remains on addressing global health needs through innovative medical solutions. The recent investments and workforce expansion reflect BD's strategic commitment to improving healthcare delivery and patient outcomes. By reinforcing its operational infrastructure and enhancing product offerings, BD aims to maintain its leadership position in the competitive healthcare market. The celebration at Broken Bow symbolizes not just a history of success, but also a future dedicated to innovation and excellence in medical technology.
In addition to this milestone, BD is undergoing a significant leadership transition, with the announcement that Chris DelOrefice, the executive vice president and chief financial officer, will depart the company on December 5. His exit coincides with BD's ongoing efforts to navigate challenges in the healthcare sector while focusing on advancing its innovative medical technology solutions. The company has not yet named a successor for DelOrefice, leaving stakeholders attentive to how this leadership change will influence BD’s strategic direction and financial strategies in the coming months.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

